Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monitoring of Donor-specific Anti-HLA Antibodies and Management of Immunosuppression in Kidney Transplant Recipients: An Evidence-based Expert Paper.
Crespo M, Zárraga S, Alonso Á, Beneyto I, Díaz Corte C, Fernandez Rodriguez AM, Franco A, Hernández D, González-Roncero FM, Jiménez Martín C, Jimeno L, Lauzurica Valdemoros LR, Llorente S, Mazuecos A, Osuna A, Ramos JP, Rodríguez Benot A, Ruiz San Millán JC, Sánchez Fructuoso A, Torregrosa JV, Guirado L; GREAT Study Group and Spanish Network for Research in Renal Diseases (REDINREN, RED16/0009). Crespo M, et al. Among authors: beneyto i. Transplantation. 2020 Aug;104(8 Suppl 2):S1-S12. doi: 10.1097/TP.0000000000003270. Transplantation. 2020. PMID: 32658025 No abstract available.
Use of the new proliferation signal inhibitor everolimus in renal transplant patients in Spain: preliminary results of the EVERODATA registry.
Ruiz JC, Sánchez A, Rengel M, Beneyto I, Plaza JJ, Zárraga S, Errasti P, Andrés A, Morales JM, Torregrosa JV, Alarcón A, Morey A, Romero R, Fernández A, Díaz JM, Cantarell C; EVERODATA Group. Ruiz JC, et al. Among authors: beneyto i. Transplant Proc. 2007 Sep;39(7):2157-9. doi: 10.1016/j.transproceed.2007.07.071. Transplant Proc. 2007. PMID: 17889123
A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function.
Andrés A, Marcén R, Valdés F, Plumed JS, Solà R, Errasti P, Lauzurica R, Pallardó L, Bustamante J, Amenábar JJ, Plaza JJ, Gómez E, Grinyó JM, Rengel M, Puig JM, Sanz A, Asensio C, Andrés I; NI2A Study Group. Andrés A, et al. Clin Transplant. 2009 Jan-Feb;23(1):23-32. doi: 10.1111/j.1399-0012.2008.00891.x. Epub 2008 Sep 16. Clin Transplant. 2009. PMID: 18798851 Clinical Trial.
Estimation of renal allograft half-life: fact or fiction?
Seron D, Moreso F, Arias M, Campistol JM, Curto J, Hernandez D, Morales JM, Sanchez-Fructuoso A, Abraira V; Spanish Late Allograft Dysfunction Study Group. Seron D, et al. Nephrol Dial Transplant. 2011 Sep;26(9):3013-8. doi: 10.1093/ndt/gfq788. Epub 2011 Feb 3. Nephrol Dial Transplant. 2011. PMID: 21292814
Prevalence and clinical characteristics of renal transplant patients with true resistant hypertension.
Arias-Rodríguez M, Fernández-Fresnedo G, Campistol JM, Marín R, Franco A, Gómez E, Cabello V, Díaz JM, Osorio JM, Gallego R; RETENAL Group (Control of Resistant Hypertension in Renal Transplant. Prevalence, Significance). Arias-Rodríguez M, et al. J Hypertens. 2015 May;33(5):1074-81. doi: 10.1097/HJH.0000000000000510. J Hypertens. 2015. PMID: 25668343
Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice.
Fernández-Ruiz M, Arias M, Campistol JM, Navarro D, Gómez-Huertas E, Gómez-Márquez G, Díaz JM, Hernández D, Bernal-Blanco G, Cofan F, Jimeno L, Franco-Esteve A, González E, Moreso FJ, Gómez-Alamillo C, Mendiluce A, Luna-Huerta E, Aguado JM; OPERA Study Group. Fernández-Ruiz M, et al. Transpl Int. 2015 Sep;28(9):1042-54. doi: 10.1111/tri.12586. Epub 2015 Apr 23. Transpl Int. 2015. PMID: 25864986 Free article.
42 results